Seguir
Annabeth P. Groenman
Annabeth P. Groenman
Afiliación desconocida
Dirección de correo verificada de uva.nl
Título
Citado por
Citado por
Año
Childhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis
AP Groenman, TWP Janssen, J Oosterlaan
Journal of the American Academy of Child & Adolescent Psychiatry, 2017
3482017
Substance use disorders in adolescents with attention deficit hyperactivity disorder: A 4‐year follow‐up study
AP Groenman, J Oosterlaan, N Rommelse, B Franke, H Roeyers, ...
Addiction 108 (8), 1503-1511, 2013
1982013
The NeuroIMAGE study: a prospective phenotypic, cognitive, genetic and MRI study in children with attention-deficit/hyperactivity disorder. Design and descriptives
D von Rhein, M Mennes, H van Ewijk, AP Groenman, MP Zwiers, ...
European child & adolescent psychiatry 24, 265-281, 2015
1792015
A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood
M van Lieshout, M Luman, JWR Twisk, H van Ewijk, AP Groenman, ...
European child & adolescent psychiatry 25, 1007-1017, 2016
1422016
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder
AP Groenman, J Oosterlaan, NNJ Rommelse, B Franke, CU Greven, ...
The British Journal of Psychiatry 203 (2), 112-119, 2013
1062013
An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder
AP Groenman, LJS Schweren, A Dietrich, PJ Hoekstra
Expert opinion on drug safety 16 (4), 455-464, 2017
632017
Meta-analysis: which components of parent training work for children with attention-deficit/hyperactivity disorder?
TJ Dekkers, R Hornstra, S van Der Oord, M Luman, PJ Hoekstra, ...
Journal of the American Academy of Child & Adolescent Psychiatry 61 (4), 478-494, 2022
572022
International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder
H Özgen, R Spijkerman, M Noack, M Holtmann, ASA Schellekens, ...
European addiction research 26 (4-5), 223-232, 2020
452020
Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
AP Groenman, LJS Schweren, W Weeda, M Luman, SDS Noordermeer, ...
European child & adolescent psychiatry 28, 1213-1222, 2019
402019
Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood
S Ilbegi, AP Groenman, A Schellekens, CA Hartman, PJ Hoekstra, ...
Journal of neurodevelopmental disorders 10, 1-8, 2018
392018
An individual participant data meta-analysis: behavioral treatments for children and adolescents with attention-deficit/hyperactivity disorder
AP Groenman, R Hornstra, PJ Hoekstra, L Steenhuis, A Aghebati, ...
Journal of the American Academy of Child & Adolescent Psychiatry 61 (2), 144-158, 2022
352022
Smoking and the developing brain: altered white matter microstructure in attention‐deficit/hyperactivity disorder and healthy controls
H van Ewijk*, AP Groenman*, MP Zwiers, DJ Heslenfeld, SV Faraone, ...
Human Brain Mapping 36 (3), 1180-1189, 2015
292015
Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder
AP Groenman, CU Greven, MMJ Van Donkelaar, A Schellekens, ...
Addiction biology 21 (4), 915-923, 2016
282016
Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4‐year prospective follow‐up
AP Groenman, J Oosterlaan, CU Greven, PJ Vuijk, N Rommelse, ...
Journal of Child Psychology and Psychiatry 56 (5), 521-529, 2015
262015
Ageing and heterogeneity regarding autism spectrum conditions: A protocol paper of an accelerated longitudinal study
HM Geurts, JAA van Rentergem, T Radhoe, C Torenvliet, ...
BMJ open 11 (3), e040943, 2021
242021
Menstruation and menopause in autistic adults: Periods of importance?
AP Groenman, C Torenvliet, TA Radhoe, JA Agelink van Rentergem, ...
Autism 26 (6), 1563-1572, 2022
212022
Parallel age‐related cognitive effects in autism: A cross‐sectional replication study
C Torenvliet, AP Groenman, TA Radhoe, JA Agelink van Rentergem, ...
Autism Research 15 (3), 507-518, 2022
202022
Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures
JO Mierau, D Kann-Weedage, PJ Hoekstra, L Spiegelaar, DEMC Jansen, ...
BMC pediatrics 20, 1-16, 2020
202020
Non‐pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta‐analysis
E Bruinsma, BJ Van Den Hoofdakker, AP Groenman, PJ Hoekstra, ...
Journal of Intellectual Disability Research 64 (8), 561-578, 2020
202020
Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming
GH Schoenmacker, AP Groenman, E Sokolova, J Oosterlaan, ...
European Neuropsychopharmacology 30, 102-113, 2020
192020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20